Amgen To Pay $780M To Settle Drug Sales Suits
Amgen Inc. said Monday it would pay $780 million to settle allegations over its sales and marketing practices stemming from civil and criminal investigations — including Medicaid claims and a whistleblower...To view the full article, register now.
Already a subscriber? Click here to view full article